CYCA Cytta Corporation (QB)

Cytta Announces Successful Launch of Doctor Direct TeleMedicine Sales Program

Significant Percentage Growth in Revenues Expected

LAS VEGAS, NV--(Marketwired - Jun 11, 2014) - Cytta Corp. (OTCQB: CYCA) announces the successful launch of our Doctor Direct sales program (www.doctordirectinc.com), by securing its first participating concierge medical practice partner. Dr. John Pierce, one of the nation's most prominent Anti-Aging doctors, with a premium concierge practice located in Las Vegas, NV, has agreed to implement the Doctor Direct TeleMedicine program with his patients.

Dr. Pierce was enthusiastic about the concept and anxious to immediately offer it to his patients. Dr. Pierce stated: "Cytta smashes the barriers that hinder me from giving deeply personalized care to my patients. Cytta Connect lets me deliver that care precisely and at a level never before possible. This revolutionizes care, making it quicker, more accurate and more convenient. With Cytta, the patient and I now become partners in creating their best health."

Doctor Direct is Cytta's new direct sales model where Cytta partners directly with participating progressive medical practices who market the Cytta Connect system to their fee paying clientele. With the rapidly growing numbers of medical practitioners providing 'concierge, retainer or boutique care,' in which a patient pays a physician an annual fee or retainer in exchange for improved access and services, the Cytta Connect system provides a valuable tool for 24/7 patient care, increased revenue and cost savings.

The primary focus of Dr. Pierce's 'Ageless Forever' practice (www.agelessforever.net) is to slow down and reverse the manifestations of the aging process. This premier concierge practice helps patients achieve their best health and appearance thru weight loss, nutrition, exercise, body sculpting, and cosmetic programs. Ageless Forever's natural hormone therapy is a medically supervised replacement of the body's age related deficient hormone production, which may include testosterone, estrogen, progesterone, DHEA, thyroid and others.

The Cytta Connect system saves time and money opening up whole new avenues of care possible in the areas of weight control, diabetes, hypertension and cardio-pulmonary diseases. The scope of what this system makes possible, and what this connectivity will ultimately make possible, is just now emerging. It is easily recognizable that the future of remote medical monitoring will be shaped by Cytta Connect.

The Doctor Direct process has been carefully refined by our expert in house medical advisors, who have defined a sales program that will allow partnering with each and every medical practice. The Doctor Direct program creates a new revenue stream for both Cytta Corp. and our Doctor Direct partners, who will be utilizing Cytta's direct marketing model to provide extraordinary care to their patients.

Cytta Connect is the first Company to combine end to end, all the necessary elements that allow our partnering doctor's to get accurate vital medical data (blood pressure, pulse, weight, O-2 saturation, blood sugar etc.) necessary to make diagnostic medical decisions remotely. The patient's data is collected with accurate, professional, double FDA approved monitors, then wirelessly sent to the physician over an encrypted, secure, HIPPA compliant, special purpose medical cell phone network. The information is stored in a cloud server (also compliant with all federal patient privacy regulations). It is immediately made available to all the care givers (doctors, nurses, hospitals, clinics) as well as, all important caretakers, including the patient, their family and loved ones.

Cytta Connect's technology will support the Doctor Direct providers in advancing clinical care to help establish high-quality, low-cost care pathways. Cytta Connect will also allow the Doctor Direct providers to extend the reach of their workforce. Cytta Connect technology and services will play a vital supporting role as Primary Care Physicians manage larger clinical teams and patient panels to help improve overall population health.

The Doctor Direct sales process will allow Cytta Connect to streamline and expand our sales and distribution utilizing each and every medical practice as a business hub with their client base as our customers.

About Cytta Corp. Cytta Corp. is an open source remote monitoring ubiquitous connectivity platform known for its highly scalable and secure Healthcare telehealth solutions. In addition to the Doctor Direct system, we are now offering the Cytta Connect technology to the Oil & Gas industry and will make available our remote data capture highway that connects monitoring devices seamlessly to a cloud-based data repository. Our remote data capture system works over our Special Purpose Network, a proprietary smartphone based, Mobile, Satellite, and WiFi open source network, and cloud-based data repository. The Cytta Connect technology automatically connects all remote monitoring devices to Cytta's cloud-based data repository creating real time communication for the Healthcare/Telehealth and Oil & Gas industries with world leading compression heretofore unavailable in the market.

Safe Harbor Statement Forward-Looking Statements Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders, competitors, and other risks detailed in the Company's Form 10-K for the year ended September 30, 2013, and other subsequent Securities and Exchange Commission filings. Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will", and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward looking statements, whether as a result of future events, new information, or otherwise. 

CONTACTS: Mr. Stuart Brame VP Corp Information Direct (702) 758-5785 Office (702) 307-1680 Email: SBrame@Cytta.com Website: Cytta.com info@cytta.com Investor Relations Contact: EraStar, Inc. Steffan Dalsgaard Principal Las Vegas, NV 89141 (775) 771-5808 office (775) 771-2244 cell